Showing results (1-10 of 131) with videos related to
Sort By:
Pageof 14
Drug Metabolism and Drug Interactions|October 23, 2013
Cytochrome P450 genetic polymorphisms of Mexican indigenous populationsMartha Sosa-Macías, Adrián LlerenaCurrent Pharmaceutical Biotechnology|September 29, 2016
Simultaneous Determination of Cytochrome P450 Oxidation Capacity in Humans: A Review on the Phenotyping Cocktail ApproachFernando de Andrés, Adrián LLerenaBritish Journal of Clinical Pharmacology|September 17, 2013
CYP2D6 variation, behaviour and psychopathology: implications for pharmacogenomics-guided clinical trialsEva M Peñas-Lledó, Adrián LlerenaPharmacogenomics|November 24, 2007
CYP2D6 polymorphism: implications for antipsychotic drug response, schizophrenia and personality traitsPedro Dorado, Eva M Peñas-Lledó, Adrián LlerenaDrug Metabolism and Personalized Therapy|March 20, 2017
An update on HLA alleles associated with adverse drug reactionsIngrid Fricke-Galindo, Adrián LLerena, Marisol López-LópezDrug Metabolism and Drug Interactions|March 11, 2014
Venlafaxine pharmacokinetics focused on drug metabolism and potential biomarkersPaulo Magalhães, Gilberto Alves, Adrián Llerena, et al.Bioanalysis|March 14, 2014
A rapid and simple LC-MS/MS method for the simultaneous evaluation of CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4 hydroxylation capacityFernando de Andrés, Martha Sosa-Macías, Adrián LlerenaPharmacogenomics|December 24, 2008
Pharmacogenetics of debrisoquine and its use as a marker for CYP2D6 hydroxylation capacityAdrián Llerena, Pedro Dorado, Eva M Peñas-LledóDrug Metabolism and Drug Interactions|October 17, 2013
Present status and perspective of pharmacogenetics in MexicoPatricia Cuautle-Rodríguez, Adrián Llerena, Juan Molina-GuarnerosJournal of Analytical Toxicology|September 7, 2017
Therapeutic Drug Monitoring of Fluoxetine, Norfluoxetine and Paroxetine: A New Tool Based on Microextraction by Packed Sorbent Coupled to Liquid ChromatographyPaulo Magalhães, Gilberto Alves, Adrián Llerena, et al.Pageof 14